The influence of glycated hemoglobin in a study comparing patients who required hospitalization or not

A study conducted at the Hospital Samaritano lasting five yrs. The HbA1c was analyzed
outpatient and hospitalized for various clinical conditions. With regard to inpatients,
according to capillary hyperglycemia observed at admission, verified by a Glucose
approved by the FDA (Food and Drug Administration) Precision XTra (Abbott) was collected
HbA1c, according to NUMAD Protocol (Multidisciplinary Center for Assistance the diabetic).
It was considered hyperglycemia blood glucose values 140 mg dl-, according to the
American Diabetes Association. Outpatients collected according to routine medical
request. HbA1c was analyzed by High Performance Liquide Chromatography (HPLC) method.
Parameters were established for analysis of glycated hemoglobin equal to or less than
6.9%, 7 to 9%, and greater than 9%. Statistical differences were considered significant
at p 0.05.